AU:RAD Stock Latest News
Company AnnouncementsRadiopharm Theranostics Advances Radiopharmaceutical Pipeline Toward Pivotal Trials4d agoRAD
Company AnnouncementsRadiopharm Theranostics Sets Fully Virtual 2026 AGM Via Automic Portal1w agoRAD
Company AnnouncementsRadiopharm unlocks $8m in R&D tax-backed funding to drive cancer trials1w agoRAD
Company AnnouncementsRadiopharm Theranostics issues 140 million unquoted options under employee incentive scheme2w agoRAD
Company AnnouncementsRadiopharm Theranostics director reduces listed option holdings2w agoRAD
Company AnnouncementsRadiopharm Theranostics updates market on cessation of RADOC options2w agoRAD
Company AnnouncementsRadiopharm Secures FDA Guidance as RAD101 Advances Toward Pivotal Brain Metastases Trial4w agoRAD
Company AnnouncementsRadiopharm Theranostics Options Lapse, Clarifying Capital Structure1M agoRAD
Company AnnouncementsRadiopharm Theranostics director options lapse after expiry1M agoRAD
Company AnnouncementsRadiopharm Theranostics Files ASX Governance Appendix 4G1M agoRAD
Company AnnouncementsRadiopharm Theranostics Files 2026 Annual Report as Nasdaq-Listed Foreign Issuer1M agoRADCompany AnnouncementsRadiopharm Theranostics Director Increases Indirect Stake via Securities Purchase Plan1M agoRAD
Company AnnouncementsRadiopharm Theranostics Issues New Unquoted ADR Warrants to Support Capital Structure1M agoRAD
Company AnnouncementsRadiopharm Theranostics Options Registry Reveals Strong Institutional Concentration1M agoRAD
Company AnnouncementsRadiopharm Theranostics Seeks ASX Quotation for New Shares and Large Option Issue1M agoRAD
Company AnnouncementsRadiopharm Theranostics Seeks ASX Quotation for Major Equity and Option Issuance1M agoRAD
Company AnnouncementsRadiopharm Theranostics Completes A$3 Million Share Purchase Plan1M agoRAD
Company AnnouncementsRadiopharm Theranostics Shareholders Back Full Suite of Capital Resolutions1M agoRAD

